SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001104659-22-105322
Filing Date
2022-10-03
Accepted
2022-10-03 16:45:42
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC TO-C tm2227297d1_sctoc.htm SC TO-C 20303
2 EXHIBIT 99.1 tm2227297d1_ex99-1.htm EX-99.1 24357
3 EXHIBIT 99.2 tm2227297d1_ex99-2.htm EX-99.2 8786
4 GRAPHIC tm2227297d1_ex99-1img001.jpg GRAPHIC 4189
  Complete submission text file 0001104659-22-105322.txt   61052
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filed by) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Subject) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-90696 | Film No.: 221288067
SIC: 2836 Biological Products, (No Diagnostic Substances)